Converus

Deal Snapshot

Company: Converus, Inc.

Website: www.converus.com 

Sector / Category: Credibility assessment / deception detection / identity verification

Headquarters: Lehi, Utah

Founded: 2010

Investor: Frazier VC

Deal Type: Primary purchases

Company Overview

Converus develops credibility assessment technologies used for deception detection and identity verification. The company’s flagship products include EyeDetect, which analyzes involuntary eye behaviors to assess deception, and IdentityDetect, which is positioned as a browser-based identity verification test.

Public Funding / Capital Events

May 16, 2017 — $4.4M raised (equity) Public reporting based on an SEC filing described Converus raising $4.4M from 21 investors.

Mar 19, 2019 — $5.61M Series B Public funding trackers list a $5.61M Series B dated March 19, 2019.

Investment Summary

Frazier VC made multiple primary purchases in Converus, Inc. from 2017 through 2024.

Why We Invested

Converus operates in a category where accuracy, scalability, and operational consistency drive adoption, particularly in screening and investigative workflows. The company’s product approach is differentiated by focusing on standardized, technology-driven testing designed to reduce time and cost versus traditional methods. Its solutions can become embedded in repeatable processes where switching costs rise as organizations train staff, implement protocols, and integrate results into decision workflows.

Other Investors

Alta Ventures

Kickstart Seed Fund

Album VC

Mark Cuban